Headquartered in Ahmedabad, India, Zydus Cadila is the fourth largest pharmaceutical company in India. It has manufacturing sites and research facilities in multiple locations across India, the United States, and Brazil. The company focuses on research areas such as new chemical entities, biologics, and vaccines. Zydus Cadila played a role in the fight against COVID-19 by manufacturing hydroxychloroquine and developing vaccine candidates for SARS-CoV-2. The company has a strong research pipeline and aims to become a global research-based pharmaceutical company.